NasdaqCM:CDTXBiotechs
Cidara Therapeutics Valuation After Clinical Trial Updates and 110% Weekly Price Surge
Ever wondered if Cidara Therapeutics could be hiding serious value, or if its recent buzz is already baked into the price? You are not alone, and a closer look may reveal more than first impressions suggest.
The stock has delivered an eye-watering 110% gain in the last week alone, and is up 1356.6% over the past year, raising both hopes for continued upside and questions about risk.
Recent news has fueled the rally, with fresh clinical trial updates and strategic partnerships sending signals...